LEO Pharma
Headquarters country
Denmark
Registry sponsor category
Industry
- Other names
- LEO Pharma
- Company name
- LEO Pharma
- Organisation type
- Industry
- Registered legal name
- LEO Pharma A/S
- Registry sponsor category
- Industry
- Website
- http://www.leo-pharma.com
- Legal Entity Identifier (LEI)
- 52990077KVK7QCK2NG31
- Wikidata ID
- Q1798020
Related records
Parent companies (1)
- LEO Holding A/S Direct parent
Trials (284)
- 21 Day Irritancy Test of Azelaic Acid Pre-foam Formulation
- A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
- A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand Eczema
- A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy
- A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus
- A Clinical Study to Evaluate the Sensitizing Potential of LEO 43204 Gel
- A Clinical Trial to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin
- A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)
- A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery
- A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic Dermatitis
- A Multi-omics Disease Signature Trial in Adult Patients With Moderate to Severe AD
- A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once Daily
- A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient
- A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
- A Phase I Study With LEO 32731 and Midazolam in Healthy Male Subjects
- A Plaque Test Comparing the Anti-psoriatic Effect of Marketed Products for Topical Use for Psoriasis Vulgaris
- A Plaque Test Study With LEO 35299 in Psoriasis Vulgaris
- A Proof of Concept Study Comparing Three Doses of an Oral Solution of LEO 22811 With a Placebo Oral Solution for the Treatment of Psoriasis Vulgaris
- A Psoriasis Plaque Test Comparing Eight Different Formulations of Vitamin D Analogues for the Treatment of Psoriasis
- A Psoriasis Plaque Test Comparing Products for the Treatment of Psoriasis Vulgaris